Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ambrx Biopharma Inc.

    NYSE: AMAM · Real-Time Price · USD
    28.00
    0.02 (0.07%)
    At close: Mar 06, 2024, 10:00 PM

    Ambrx Biopharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -78M -68.29M
    Depreciation & Amortization
    		 1.8M 2.15M
    Stock-Based Compensation
    		 6.25M 11.86M
    Other Working Capital
    		 -9.65M -4.08M
    Other Non-Cash Items
    		 11.89M 5.49M
    Deferred Income Tax
    		 n/a 513K
    Change in Working Capital
    		 -10.62M 3.64M
    Operating Cash Flow
    		 -68.67M -44.64M
    Capital Expenditures
    		 -1.05M -3.21M
    Cash Acquisitions
    		 45.66M n/a
    Purchase of Investments
    		 -84.85M n/a
    Sales Maturities Of Investments
    		 39.19M n/a
    Other Investing Acitivies
    		 -45.66M n/a
    Investing Cash Flow
    		 -46.72M -3.21M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 928K 127.43M
    Financial Cash Flow
    		 928K 127.43M
    Net Cash Flow
    		 -114.47M 79.63M
    Free Cash Flow
    		 -69.73M -47.85M

    Add to Watchlist